BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
rs7903146
,
IGF1
,
Response to oxidative stress
,
Obesity
,
Adipose tissue
,
Aspirin
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
hemangiosarcoma
Summary
General Info
Curated Studies
Most Correlated Studies
Hemangiosarcoma cells from various dog breeds
Canine hemangiosarcoma cell lines and tissues with varying IL-8 expression
Bone marrow, liver and spleen profiles from B6C3F1 mice treated with 2-butoxyethanol or hypoxia
Liver, spleen, and bone marrow of mice treated with baclofen
Explore Curated Studies Results
Literature
Most Relevant Literature
Disseminated Hemangiosarcoma in a Mare Mule.
MRI features of canine hemangiosarcoma affecting the central nervous system.
KDM2B promotes cell viability by enhancing DNA damage response in canine hemangiosarcoma.
Timely adjuvant chemotherapy improves outcome in dogs with non-metastatic splenic hemangiosarcoma un…
New molecular targets in canine hemangiosarcoma-Comparative review and future of the precision medic…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
S0505 Sorafenib in Treating Patients With Advanced Soft Tissue Sarcomas
An Open-Label Comparison of Duloxetine to Other Alternatives for the Management of Diabetic Peripher…
Radiotherapy Concurrent With Apatinib in Advanced Soft Tissue and Bone Sarcomas of Head and Neck--RA…
Albumin-bound Paclitaxel Plus Camrelizumab for Advanced Soft Tissue Sarcoma.
A Phase II Study of Sunitinib or Temsirolimus in Patients With Advanced Rare Tumours
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ